Semaglutide

GLP-1 receptor agonist for weight loss and diabetes management.

Benefits

Promotes significant weight loss by reducing appetite and increasing satiety

Lowers blood sugar level and enhances insulin secretion

May improve cardiovascular health by reducing risk factors

Potential neuroprotective effects, possibly reducing Alzheimer’s disease progression

May improve liver and lung function

Mechanism of Action

A glucagon-like peptide-1 (GLP-1) receptor agonist, mimicking the effects of GLP-1, an incretin hormone. Enhances insulin release in a glucose-dependent manner, reduces Glucagon secretion and slows gastric emptying, leading to a better blood sugar control and reduced appetite. Acts on the central nervous system to regulates safety and reduce food intake.

99% Purity Research Grade Fast, Free Shipping

For research purposes only. Not for human consumption.

Your Bag